Previous studies have indicated that TDP-43 immunoreactive inclusion bodies can be detected in other neurodegenerative disorders as well, including Alzheimer’s disease (AD) [5–9], Lewy body disease (LBD) [6, 8, 10], and argyrophilic grain disease (AGD) [11]. This evidence concerns the gene TARDBP and Lewy body dementia.